Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-09-15
2011-12-27
Murray, Jeffrey (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S242000
Reexamination Certificate
active
08084457
ABSTRACT:
The present invention relates to 4,6-disubstituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, prion diseases, immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases and stroke, and pharmaceutical compositions containing at least one of said 4,6-di substituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof. Furthermore, the present invention relates to the use of said 4,6-disubstituted aminopyrimidine derivatives as inhibitors for a protein kinase and a medium comprising at least one of said 4,6-disubstituted aminopyrimidine derivatives in an immobilized form and the use of said medium for enriching, purifying and/or depleting nucleotide binding proteins which bind to the immobilized 4,6-disubstituted aminopyrimidine derivatives.
REFERENCES:
patent: 3908012 (1975-09-01), De Angelis et al.
patent: 3950525 (1976-04-01), De Angelis et al.
patent: 4725600 (1988-02-01), Takaya et al.
patent: 2004/0204386 (2004-10-01), Bhatt et al.
patent: 0168262 (1986-01-01), None
patent: 02096867 (2002-12-01), None
Luo, et. al., Tettrahedron Letters, 43, (2002), pp. 5739-5742.
Schmidt, et. al., Journal of Heterocyclic Chemistry, 39, (2002), pp. 949-956.
Falch E et al: “Substituted Heteroaromatic Anthranilic Acids With Antiinflammatory Activity” Journal of Medicinal Chemistry, American Chemical Society. Washington, US, vol. 11, No. 3, May 1968, pp. 608-611, XP001069203.
El-Reedy A M et al: “Azolopyrimidines and Pyrimidoquinazolines From 4-Chloropyrimidines” Journal of Heterocyclic Chemistry, Heterocorporation. Provo, US, vol. 26, No. 2, 1989, pp. 313-316, XP000929372.
Clare, Paula M. et al: “The Cyclin-Dependent Kinases cdk2 and cdk5 Act by A Random, Anticooperative Kinetic Mechanism” Journal of Biological Chemistry, 256(51), 48292-48299, 2001, XP002312583.
Backes Alexander
Bravo Jose
Choidas Axel
Cotten Matt
Engkvist Ola
Bayer Pharma AG
Lead Discovery Center GmbH
Meyertons Eric B.
Meyertons Hood Kivlin Kowert & Goetzel P.C.
Murray Jeffrey
LandOfFree
Pharmaceutically active 4,6-disubstituted aminopyrimidine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutically active 4,6-disubstituted aminopyrimidine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically active 4,6-disubstituted aminopyrimidine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4302890